This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

InterMune's CEO Discusses France's Economic Committee's (CEPS) Authorization Of Reimbursement Of Esbriet Conference (Transcript)

Stocks in this article: ITMN

InterMune Inc. (ITMN)

France's Economic Committee (CEPS) Authorizes Reimbursement of Esbriet Conference Call

September 11, 2012, 08:00 am ET

Executives

Jim Goff - VP, Corporate Communications & IR

Dan Welch - Chairman, CEO and President

Giacomo Di Nepi - SVP and Managing Director, Europe

Analysts

Brian Abrahams - Wells Fargo Securities

Ritu Baral - Canaccord

Katherine Xu - William Blair

Michael Yee - RBC Capital Markets

Geoff Meacham - JPMorgan

Terence Flynn - Goldman Sachs

Matthew Harrison - UBS

Liisa Bayko - JMP Securities

Presentation

Operator

Ladies and gentlemen thank you for standing by. Welcome to the Esbriet Reimbursement in France conference call. During the presentation all participants will be in a listen-only mode. Afterwards will conduct a question-and-answer session. (Operator Instructions) As a remainder this conference is being recorded today Tuesday September 11, 2012. I will now like to turn the conference over to Jim Goff VP Investor Relations for InterMune. Please go ahead, sir.

Jim Goff

Thank you operator. Good morning everyone and welcome to this InterMune conference call. This morning we issued a press release that discusses the pricing, the reimbursement and launch timing of Esbriet in France. That press release is available on our website at www.intermune.com.

During the course of this conference call we will state our beliefs and make projections and other forward-looking statements regarding future events and the future financial performance of InterMune and wish to caution you that such statements or predictions and expectations and actual events are results that may differ materially. We refer you to the company's publicly filed SEC disclosure documents for a detailed description of the risk factors affecting our business including those discussed in our Form 10-K filed with the SEC on February 29 2012 and Form 10-Q filed with the SEC on august 8 2012.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs